Clinics I work with
Selected research
-
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
Acta neuropathologica
-
Glioblastoma remodelling of human neural circuits decreases survival.
Nature
-
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
Acta neuropathologica